Trial intelligence / Profile preview

Phase 2 study of SKY0402 for post-operative pain after inguinal hernia repair

2004-002342-35Phase 2Completed

Sponsor
SkyePharma, Inc.
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of bupivacaine liposome in acute postoperative pain (2 arms), sponsored by SkyePharma, Inc. Primary endpoint: Time to first use of supplemental pain medication. Started Feb 2005; status: completed.

02

Drugs

bupivacaine liposome
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on 2004-002342-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002342-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call